secwatch.observer — SEC 8-K summary
======================================

Issuer:     PERRIGO Co plc (PRGO)
CIK:        0001585364
Form:       8-K
Filed at:   2025-07-14T23:59:59+00:00
Accession:  0001193125-25-158493
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perrigo to sell Dermacosmetics business to KKR for up to €327M
--------------------------------------------------------------

- Upfront cash €300M, plus up to €27M milestone payments over three years.
- Divestiture includes brands ACO, Biodermal, Emolium, Iwostin; 2024 net sales ~€125M.
- Expected to close Q1 2026; net proceeds to strengthen balance sheet.
- Advances Perrigo's 'Three-S' plan to streamline portfolio and focus on high-growth brands.
- Business generated ~5% of Perrigo's 2024 adjusted operating income.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585364/000119312525158493/0001193125-25-158493-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585364/000119312525158493/d89351d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-158493

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer